Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mari Hosonaga
Observed names:
M Hosonaga,
M. Hosonaga
Institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
Observed institutions:
Tokyo Medical University,
Keio University,
Tokyo Medical University Hospital,
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
ORCID:
0000-0001-8525-2941
Observed ORCID:
0000-0001-8525-2941
OpenAlex ID:
A5091499529
Molecular and cellular mechanisms underlying brain metastasis of breast cancer
2020
·
Mari Hosonaga
, Hideyuki Saya
, et al.
·
Cancer and Metastasis Reviews
·
174
PDF
Induction of ZEB Proteins by Inactivation of RB Protein Is Key Determinant of Mesenchymal Phenotype of Breast Cancer
2012
·
Yoshimi Arima
, Hidemi Hayashi
, et al.
·
Journal of Biological Chemistry
·
79
Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial)
2023
·
Jun Masuda
, Hitomi Sakai
, et al.
·
Journal for ImmunoTherapy of Cancer
·
76
PDF
Expression of CD 24 is associated with HER2 expression and supports HER2‐Akt signaling in HER2‐positive breast cancer cells
2014
·
Mari Hosonaga
, Yoshimi Arima
, et al.
·
Cancer Science
·
48
PDF
HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer
2018
·
Mari Hosonaga
, Yoshimi Arima
, et al.
·
International Journal of Molecular Sciences
·
39
PDF
Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer
2022
·
Yoon Ming Chin
, Tomoko Shibayama
, et al.
·
Cancer Science
·
38
PDF
RNA Sequencing Analysis Reveals Interactions between Breast Cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis
2017
·
Ryo Sato
, Teppei Nakano
, et al.
·
BioMed Research International
·
37
Proposal for Managing Cancer‐Related Insomnia: A Systematic Literature Review of Associated Factors and a Narrative Review of Treatment
2024
·
Yoshinori Saeki
, Yukiyoshi Sumi
, et al.
·
Cancer Medicine
·
21
PDF
Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice
2023
·
Ippei Fukada
, Seiichi Mori
, et al.
·
Cancer Science
·
21
A lower dose of docetaxel at 60 mg/m2 could be continued longer for controlling peripheral edema in patients with metastatic breast cancer
2011
·
Mari Hosonaga
, Yoshinori Ito
, et al.
·
Breast Cancer
·
17
Abstract PS12-10: Phase II study of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR+, HER2- metastatic breast cancer: WJOG11418B NEWFLAME trial
2021
·
Jun Masuda
, Junji Tsurutani
, et al.
·
Cancer Research
·
15
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world study
2024
·
Yosuke Aoyama
, Yukinori Ozaki
, et al.
·
Breast Cancer
·
11
Assessment of a cancer genomic profile test for patients with metastatic breast cancer
2022
·
Ippei Fukada
, Seiichi Mori
, et al.
·
Scientific Reports
·
11
PDF
Availability of genome-matched therapy based on clinical practice
2024
·
Naomi Hayashi
, Seiichi Mori
, et al.
·
International Journal of Clinical Oncology
·
10
PDF
Hereditary breast cancer associated with Cowden syndrome-related PTEN mutation with Lhermitte-Duclos disease
2017
·
Fuyo Kimura
, Ai Ueda
, et al.
·
Surgical Case Reports
·
10
Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study
2022
·
Yukinori Ozaki
, Yosuke Aoyama
, et al.
·
BMC Cancer
·
9
PDF
Influence of menopause on chemotherapy‐induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study
2023
·
Takashi Yokokawa
, Kenichi Suzuki
, et al.
·
Cancer Medicine
·
8
PDF
Objection to postoperative radiation therapy in breast cancer with one to three lymph nodes involvements
2017
·
Takashi Ishikawa
, Hiroshi Kaise
, et al.
·
Breast Cancer
·
8
Erratum to: Objection to postoperative radiation therapy in breast cancer with one to three lymph nodes involvements
2017
·
Takashi Ishikawa
, Hiroshi Kaise
, et al.
·
Breast Cancer
·
6
PDF
Absolute lymphocyte count predicts efficacy of palbociclib in patients with metastatic luminal breast cancer
2024
·
Takayuki Kobayashi
, Meiko Nishimura
, et al.
·
BMC Cancer
·
5
PDF
Addressing the knowledge gap in the genomic landscape and tailored therapeutic approaches to adolescent and young adult cancers
2024
·
N. Hayashi
, M. Ono
, et al.
·
ESMO Open
·
4
PDF
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers
2024
·
Mari Hosonaga
, Eri Habano
, et al.
·
Breast Cancer
·
3
Evaluation of an inflammation-based score for identification of appropriate patients for comprehensive genomic profiling
2022
·
Naomi Hayashi
, Ippei Fukada
, et al.
·
Discover Oncology
·
3
PDF
Accuracy and validity of sentinel lymph node biopsy for breast cancer using a photosensitizer: 8-year follow-up
2013
·
Kimito Yamada
, Akihiko Ogata
, et al.
·
Lasers in Surgery and Medicine
·
3
Automated and Decentralized Genomic Profiling of Plasma Cell-Free DNA for Identification of Targetable and Resistance Alterations in Advanced Solid Tumors
2025
·
Hiu Ting Chan
, Masumi Otaki
, et al.
·
Clinical Chemistry
·
2
PDF
Show more works
View as search
Works count:
72
Citation count:
668
H-index:
11
I10-index:
15
Year
Topic
Type